Company Quick10K Filing
FTE Networks
10-K 2019-12-31 Filed 2020-11-05
10-K 2018-12-31 Filed 2020-05-11
10-Q 2018-09-30 Filed 2018-11-19
10-Q 2018-06-30 Filed 2018-08-14
10-Q 2018-03-31 Filed 2018-05-21
10-K 2017-12-31 Filed 2018-04-18
10-Q 2017-09-30 Filed 2017-11-16
10-Q 2017-06-30 Filed 2017-08-21
10-Q 2017-03-31 Filed 2017-05-25
10-K 2016-12-31 Filed 2017-05-11
10-Q 2016-09-30 Filed 2016-11-21
10-Q 2016-06-30 Filed 2016-08-16
10-Q 2016-03-31 Filed 2016-05-16
10-K 2015-09-30 Filed 2016-01-13
10-Q 2015-06-30 Filed 2015-08-19
10-Q 2012-06-30 Filed 2012-08-14
10-Q 2012-03-31 Filed 2012-05-01
10-Q 2011-12-31 Filed 2012-02-08
8-K 2020-09-25
8-K 2020-05-21
8-K 2020-05-15
8-K 2020-03-30
8-K 2020-03-10
8-K 2020-03-09
8-K 2020-02-27
8-K 2020-02-21
8-K 2020-01-16
8-K 2019-12-30
8-K 2019-12-20
8-K 2019-12-17
8-K 2019-12-11
8-K 2019-11-08
8-K 2019-10-18
8-K 2019-10-14
8-K 2019-10-09
8-K 2019-10-02
8-K 2019-09-16
8-K 2019-09-12
8-K 2019-08-31
8-K 2019-07-02
8-K 2019-07-01
8-K 2019-06-28
8-K 2019-06-24
8-K 2019-06-14
8-K 2019-06-12
8-K 2019-06-11
8-K 2019-06-05
8-K 2019-05-29
8-K 2019-05-28
8-K 2019-05-11
8-K 2019-05-09
8-K 2019-05-07
8-K 2019-05-03
8-K 2019-04-30
8-K 2019-04-24
8-K 2019-04-17
8-K 2019-04-16
8-K 2019-04-09
8-K 2019-04-09
8-K 2019-04-05
8-K 2019-04-02
8-K 2019-04-01
8-K 2019-03-30
8-K 2019-03-25
8-K 2019-02-26
8-K 2019-02-20
8-K 2019-02-12
8-K 2019-01-17
8-K 2018-12-26
8-K 2018-12-19
8-K 2018-12-18
8-K 2018-12-04
8-K 2018-11-20
8-K 2018-11-15
8-K 2018-10-30
8-K 2018-09-25
8-K 2018-08-15
8-K 2018-08-06
8-K 2018-07-09
8-K 2018-05-21
8-K 2018-04-18
8-K 2018-04-03
8-K 2018-03-21
8-K 2018-03-12
8-K 2018-01-10

FTE Networks Financials

FTNW Metrics, Comps, Filings

Quarterly | Annual

Valuation ($MM)

Market Cap, Enterprise Value

Balance Sheet ($MM)

Assets, Equity

Income Statement ($MM Quarterly)

Revenue, G Profit, Net Income

Cash Flow ($MM Quarterly)

Ops, Inv, Fin

Comps ($'000 TTM) Market Cap Gross Margin EV/EBITDA Ret on Assets Assets Liabilities Revenue G Profit Net Income EBITDA EV
20 20 Global (TWGL)
024 Pharma (EEIG)
111 (YI) 0% 1,546,418 322,654 0 0 0 0 -853,740
1 800 Flowers Com (FLWS) 944,324 42% 13.3 6% 664,955 335,559 1,266,390 533,727 36,761 75,090 1,000,932
10x Genomics (TXG) 4,804,979 75% -490.3 -2% 572,815 151,367 61,207 45,727 -9,603 -8,887 4,357,180
12 Retech (RETC) 0 32% -0.1 -1,385% 1,118 20,421 625 199 -15,491 -14,800 966
11 Good Energy (ELVN)
1347 Property Insurance Holdings (PIH) 33,711 0% 0.4 -5% 164,088 108,405 18,194 0 -7,969 -8,017 -2,855
1347 Capital Corp (TFSC)
180 Degree Capital (TURN)
1847 Holdings (EFSH) 25% -2.4 -15% 18,527 23,194 27,219 6,699 -2,862 -1,433 3,396
1895 Bancorp of Wisconsin (BCOW) 46,152,715 12,508.1 -0% 441,187 382,722 0 0 -44 3,689 46,142,359
1st Constitution Bancorp (FCCY) 164,504 0% 4.4 1% 1,342,565 1,204,038 490 0 13,787 32,503 143,748
1st Franklin Financial (FFC) 3,551 -0.6 7% 905,107 644,730 0 0 62,078 80,004 -45,962
24 7 Kid Doc (TVMD)
1st Source (SRCE) 1,200,033 7.9 1% 6,691,070 5,858,028 0 0 70,061 136,342 1,072,548
2050 Motors (ETFM) 0 -0.2 -166,272,400% 0 1,849 0 0 -1,663 -1,654 250
21Vianet Group (VNET) 6,005,116 0% 11,150,717 5,787,533 0 0 0 0 3,344,095
22nd Century (XXII) 301,854 1% -14.1 -36% 61,864 6,554 25,706 304 -22,433 -21,464 301,826
1Life Healthcare (ONEM)

Balance Sheet ($'000)2011-06-302011-09-302011-12-312012-03-312015-06-302015-09-302016-03-312016-06-302016-09-302016-12-312017-03-312017-06-302017-09-302017-12-312018-03-312018-06-302018-09-30
Cash6948612,0878931902081557791,41227,8353,15415,6429,63812,8845,722
Accounts Receivable3,2893,7523,5762,9852,3121,2152,7014,0997,0257,0209,98536,70751,79162,19978,25172,69375,812
Inventory566000
PP&E3322492832687491,6202,6103,0493,2694,2804,3005,5567,1019,6398,1219,1659,956
Assets11,36011,92213,52811,8024,1074,8958,7389,69213,13214,73117,936139,042149,774167,647171,459164,624158,877
Accounts Payable2,1843,2042,3222,4271,9542,4773,2673,0052,2332,3572,33322,25533,53135,13546,09540,17529,307
Long-Term Debt5924004785,8671,5562,4472,27619,4777,30058,99360,9211,9551,9341,6171,414
Liabilities7,1988,36310,0559,68413,64116,02019,32719,95222,01324,59427,992126,469133,220159,614158,670161,735164,442
Stockholders' Equity4,1623,5593,4732,118-9,533-11,126-11,026-10,697-9,318-10,301-10,49312,57316,5548,03312,7892,889-5,565
Income Statement ($'000)2011-06-302011-09-302011-12-312012-03-312015-06-302015-09-302016-03-312016-06-302016-09-302016-12-312017-03-312017-06-302017-09-302017-12-312018-03-312018-06-302018-09-30
Revenue4,5025,4156,0023,3174,0714,0262,0933,1633,8283,1855,08651,95579,083108,54385,14592,42892,224
Cost of Revenue2,3092,8673,6852,0753,1473,4751,3131,9332,4033,1992,67842,65263,55397,78673,65482,51676,311
Gross Profit2,0122,1312,3171,2429235517801,2291,425-142,4089,30315,53010,75711,49113,95215,913
R&D
SG&A1,3028127821,042568997559815547-1849753,9564,1594,8154,1995,2579,045
Tax750320-1212311,76356810268
Net Income-396-804-567-1,524-1,501-1,544-1,099-1,059-1,032-3,044-3,971-5,0932,549-13,516-10,164-13,558-12,025
Cash Flow ($'000)2011-06-302011-09-302011-12-312012-03-312015-06-302015-09-302016-03-312016-06-302016-09-302016-12-312017-03-312017-06-302017-09-302017-12-312018-03-312018-06-302018-09-30
Cash Operating199524-1,324-264-2,088-3,221-4,746-3,4144,498-6,0429,088-5,2932,116-6,489
Cash Investing-23-85-30-192,238-91-539-972-16,253-1,640-1,177-541-1,518-1,154
Cash Financing-66646222302-2003,2176,6892,97619,5883,0014,577-1702,648217